HigherHighs
RankingLoading... stocks
Australia
AU
Healthcare
Biotechnology
1W
1M
3M
6M
1Y
2Y
5Y
All
ABOUT Biotron Ltd
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is based in Sydney, Australia.